Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma - Concepedia

Concepedia

Publication | Closed Access

Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma

144

Citations

45

References

2011

Year

Yukino Kimura, Jun Tsukada, Takeshi Tomoda, Hidenori Takahashi, Kazuhiro Imai, Kanae Shimamura, Makoto Sunamura, Yoshikazu Yonemitsu, Shigetaka Shimodaira, Shigeo Koido,

Abstract

Dendritic cell vaccine-based immunotherapy combined with chemotherapy was shown to be safe and possibly effective in patients with advanced pancreatic cancer refractory to standard treatment.

References

	Year	Citations

Page 1